Publications

Integrative clinical and preclinical studies identify FerroTerminator1 as a potent therapeutic drug for MASH

 104
Integrative clinical and preclinical studies identify FerroTerminator1 as a potent therapeutic drug for MASH

Tags:

Previous Article

Human Schwann cell lipid dysregulation and plasma membrane perturbation in Charc...

Next Article

FerroTerminator1 as a potent therapeutic drug for MASH

Related Posts

Sleep chart of biological ageing clocks in middle and late life

Sleep chart of biological ageing clocks in middle and l...

 81

Disease-specific suppressive granulocytes participate in glioma progression

Disease-specific suppressive granulocytes participate i...

 97

Adenosine signaling driven by the gut microbiota underlies chronic alcohol-induced anesthetic resistance

Adenosine signaling driven by the gut microbiota underl...

 69